🇺🇸 FDA

Company profile · Sponsor

International

International Peace Maternity and Child Health Hospital

C286472 · NMPA pharma CN
Pipeline
21
Drugs
0
Patents
0

Quick answer

International (C286472) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 21 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C286472
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (21)

Search pipeline →

  1. Chemotherapy

    International

    Non Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  2. Olokizumab

    International

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  3. Olokizumab 64 mg SC q4w

    International

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  4. Olokizumab 64mg q4w

    International

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  5. Radiotherapy

    International

    Cervix Cancer

    phase 3 other completed

    1 trial

  6. Tamoxifen

    International

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  7. ZX008 (Fenfluramine Hydrochloride)

    International

    Dravet Syndrome

    phase 3 small molecule completed

    1 trial

  8. Bivalent killed oral cholera vaccine

    International

    Cholera

    phase 2 mab active

    1 trial

  9. HBI-3000

    International

    Atrial Fibrillation

    phase 2 small molecule active

    1 trial

  10. killed oral cholera vaccine

    International

    Cholera

    phase 2 mab completed

    1 trial

  11. Recombinant human arginase 1 Peg5000

    International

    Leukemia

    phase 1 small molecule terminated

    1 trial

  12. iridoid enriched mixed fruit beverage

    International

    Oxidative Stress

    phase 1 other completed

    1 trial

  13. DePuy ASR Hip System

    International

    Rheumatoid Arthritis

    approved other terminated

    1 trial

  14. Elobixibat 10mg

    International

    Chronic Constipation

    approved small molecule terminated

    1 trial

  15. LCS® Complete™ Mobile Bearing Knee Systems

    International

    Knee Osteoarthritis

    approved other completed

    1 trial

  16. Typhoid Vi vaccine

    International

    Typhoid

    approved mab completed

    1 trial

  17. Cy-TB test

    International

    Latent Tuberculosis

    other completed

    1 trial

  18. Evaluation of social, cultural and behavioral factors

    International

    Cardio-vascular Disease

    other completed

    1 trial

  19. External beam radiotherapy

    International

    Squamous Cell Carcinoma of the Head and Neck

    other active

    1 trial

  20. Letrozole

    International

    Letrozole

    small molecule active

    1 trial

  21. On-site radiologist

    International

    Tuberculosis

    other completed

    1 trial

Frequently asked questions

What is International?

International (C286472) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 21 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does International sponsor?

We track 21 ClinicalTrials.gov-linked programs for International, including Chemotherapy and 20 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does International company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.